Avenue Therapeutics Inc (ATXI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.3620 +0.0070 (+1.97%) 03/21/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.3620 unch (unch) 15:53 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -10,488 | -3,603 | -3,731 | -5,151 | -25,908 |
Accounts receivable | N/A | 90 | N/A | N/A | N/A |
Other Working Capital | -290 | 408 | -461 | -172 | -2,251 |
Other Operating Activity | 1,327 | -4,491 | 442 | 710 | 1,900 |
Operating Cash Flow | $-9,451 | $-7,596 | $-3,750 | $-4,613 | $-26,259 |
Cash Flows From Investing Activities | |||||
Other Investing Activity | -3,000 | 0 | 0 | -1,000 | 0 |
Investing Cash Flow | $-3,000 | $N/A | $N/A | $-1,000 | $0 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 7,526 | 11,645 | 5,044 | N/A | 35,000 |
Common Stock Repurchased | N/A | -1,104 | N/A | N/A | N/A |
Other Financing Activity | 0 | 0 | -663 | 0 | -2,667 |
Financing Cash Flow | $7,526 | $10,541 | $4,381 | $0 | $32,333 |
Beginning Cash Position | 6,708 | 3,763 | 3,132 | 8,745 | 2,671 |
End Cash Position | 1,783 | 6,708 | 3,763 | 3,132 | 8,745 |
Net Cash Flow | $-4,925 | $2,945 | $631 | $-5,613 | $6,074 |
Free Cash Flow | |||||
Operating Cash Flow | -9,451 | -7,596 | -3,750 | -4,613 | -26,259 |
Free Cash Flow | -9,451 | -7,596 | -3,750 | -4,613 | -26,259 |